000			02640cam a2200373Mi 4500
001			94987
003			ES-MaUEC
005			20230102112641.0
006			m o d
007			cr |n|||||||||
008			161202s2017 sz ob 000 0 eng d
020			_a3319280406 _q(electronic bk.)
020			_a9783319280400 _q(electronic bk.)
020			_z3319280392
020			_z9783319280394
035			_a(OCoLC)965145559 _z(OCoLC)964656834 _z(OCoLC)970811397 _z(OCoLC)971032746 _z(OCoLC)974651442 _z(OCoLC)975845355 _z(OCoLC)1005770094
040			_aYDX _cYDX _dN$T _dIDEBK _dGW5XE _dOCLCF _dN$T _dAZU _dUAB _dCOO _dOCLCQ _dUPM _dMERUC _dIOG _dMERER _dESU _dOCLCQ _dJBG _dIAD _dICW _dICN _dOTZ _dOCLCQ _dVT2 _dOHS _dU3W _dES-MaUEC _bspa
050		4	_aQR185.8.I56 _b2017 EB
100	1		_aChu, Cong-Qiu. _eautor
245	1	0	_aTargeting the IL-17 pathway in inflammatory disorders _cCong-Qiu Chu.
264		1	_aCham, Switzerland _bAdis _c2017
300			_a1 recurso en línea
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF _2rda
504			_aIncluye referencias bibliográficas
505	0		_aIntroduction -- Overview of IL-17 family.-Il-17 in host defense -- Th17 cells: differentiation and regulation -- The role of the IL-17/Th17 pathway in the pathogenesis of autoimmune inflammatory diseases -- Therapeutic applications: strategies and molecules targeting the IL-17/Th17 pathway -- Concluding remarks.
520	3		_aThis book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.
650		7	_aInflamación _2embne _0(OCoLC)fst00972432 _0 _9153270
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-28040-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988			_aSpringer_Medicine_2017
998			_b02/2018 _dz _e- _zSI
999			_c94987 _d94987 _x1